Dr. Gábor Simonyi MD, PhD, FAHA, FISHNE
Dr. Gábor Simonyi MD, PhD, FAHA, FISHNE
St Imre University Teaching Hospital
Verified email at
Cited by
Cited by
Benefits of fixed dose combination of ramipril/amlodipine in hypertensive diabetic patients: a subgroup analysis of RAMONA trial
G Simonyi
Chinese medical journal 129 (10), 1224-1228, 2016
The pharmacological treatment of obesity: Past, present and future
G Simonyi, G Pados, M Medvegy, JR Bedros
Orvosi hetilap 153 (10), 363-373, 2012
Ramipril+ amlodipine and ramipril+ hydrochlorothiazide fixed-dose combinations in relation to patient adherence
G Simonyi, T Ferenci, S Alföldi, C Farsang
Journal of International Medical Research 44 (5), 1087-1091, 2016
Changes in triglyceride, HDL-C, and non-HDL-C levels in patients with acute coronary syndrome
P Koncsos, P Fülöp, I Juhász, K Bíró, L Márk, G Simonyi, G Paragh
Wiener Klinische Wochenschrift 128 (23), 858-863, 2016
Electrocardiological features in obesity: the benefits of body surface potential mapping
G Simonyi
Cardiorenal Medicine 4 (2), 123-129, 2014
Obesity and hypertension
G Simonyi, R Kollár
Orvosi Hetilap 154 (44), 1736-1742, 2013
Hungarian policemen study on the prevalence of obesity
L Halmy, G Simonyi, T Csatai, A Paksy
Int J Obes 227, S1-S132, 2003
Silent hypoglycaemic episodes among well controlled type 2 diabetic patients treated with sulfonylureas
G Simonyi, G Csitári, R Gasparics, R Kollár
Diabetologia 58 (Suppl 1), S465, 2015
Significance of patient adherence in cardiovascular therapy
G Simonyi, R Kollár
Orvosi Hetilap 154 (23), 883-888, 2013
New possibility in the oral glucose lowering treatment of type 2 diabetes mellitus: sodium-glucose co-transporter-2 inhibitors
G Simonyi
Orvosi hetilap 153 (18), 695-701, 2012
Persistence on treatment with the fixed combination of ramipril and amlodipine
G Simonyi, T Ferenci
Orvosi Hetilap 155 (47), 1882-1888, 2014
Lipid-lowering therapy and patient adherence in the MULTI GAP 2013 trial
G Simonyi
Orvosi Hetilap 155 (17), 669-675, 2014
Non-ST elevation myocardial infarction: a new pathophysiological concept could solve the contradiction between accepted cause and clinical observations
M Medvegy, G Simonyi, N Medvegy, Z Pécsvárady
Acta Physiologica Hungarica 98 (3), 252-261, 2011
Diagnosis and discrimination of remote antero-and inferoseptal non-Q wave myocardial infarctions with body surface potential mapping
M Medvegy, R Nadeau, E Szücs, K Szakolczai, G Simonyi, T Bauernfeind, ...
Canadian Journal of Cardiology 24 (1), 53-55, 2008
Ramipril plus amlodipine and lisinopril plus amlodipine fixed dose combinations and patient's adherence
G Simonyi, T Ferenci
Orvosi Hetilap 157 (1), 30-34, 2016
Diagnostic value of the left atrial electrical potentials detected by body surface potential mapping in the prediction of coronary artery disease
T Bauernfeind, I Préda, K Szakolczai, E Szűcs, RG Kiss, G Simonyi, ...
International journal of cardiology 150 (3), 315-318, 2011
Diagnostic value of body surface potential mapping in assessment of the coronary artery lesion after angina pectoris and without repolarization changes on the electrocardiogram
E Szűcs, K Szakolczai, G Simonyi, T Bauernfeind, A Pintér, I Préda, ...
Journal of Electrocardiology 43 (4), 326-335, 2010
Persistence of fixed and free combination of perindopril and amlodipine in hypertension
G Simonyi, T Ferenci, M Medvegy
European Heart Journal 37, 1-189, 2016
A ramipril/amlodipin és a lisinopril/amlodipin fix kombinációk a terápiahűség tükrében
G Simonyi, T Ferenci
Orvosi Hetilap 157 (1), 30-34, 2016
Persistence of vitamin K antagonist therapy in the real world
G Simonyi, MP Molnar
Eur Heart J 35, 726-727, 2014
The system can't perform the operation now. Try again later.
Articles 1–20